Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Costeffectiveness of routine cytological cervical surveillance following treatment for carcinoma of cervix

Costeffectiveness of routine cytological cervical surveillance following treatment for carcinoma... Objectives The costeffectiveness of routine cervical cytology during followup after treatment for carcinoma of cervix is examined. Subjects All patients having routine followup smears during the financial year 19931994. A total of 212 patients generated 311 smears, 96 had an intact cervix and 116 had surgical removal as part of their treatment. Ninetyone patients with intact cervices and 109 without were evaluable. Results Nine recurrences were detected, in every case this was expected, based on clinical findings. In two of these the smear was reported as normal. Two hundred and thirty smears were from entirely asymptomatic patients. Conclusions Limiting cervical smears to those who are symptomatic, or where an abnormality is found on examination, would save approximately 3500 per year. This cost needs to be set beside the possibility of detecting an asymptomatic recurrence at an early stage as reported by others. This suggests that the impact of this strategy is limited. A randomized trial with prospective economic assessment would be the only way to evaluate the costeffectiveness of routine cervical smears in the followup of patients treated for cancer of cervix. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Clinical Effectiveness Emerald Publishing

Costeffectiveness of routine cytological cervical surveillance following treatment for carcinoma of cervix

Loading next page...
 
/lp/emerald-publishing/costeffectiveness-of-routine-cytological-cervical-surveillance-4k7JTFv0aX
Publisher
Emerald Publishing
Copyright
Copyright © Emerald Group Publishing Limited
ISSN
1361-5874
DOI
10.1108/eb020870
Publisher site
See Article on Publisher Site

Abstract

Objectives The costeffectiveness of routine cervical cytology during followup after treatment for carcinoma of cervix is examined. Subjects All patients having routine followup smears during the financial year 19931994. A total of 212 patients generated 311 smears, 96 had an intact cervix and 116 had surgical removal as part of their treatment. Ninetyone patients with intact cervices and 109 without were evaluable. Results Nine recurrences were detected, in every case this was expected, based on clinical findings. In two of these the smear was reported as normal. Two hundred and thirty smears were from entirely asymptomatic patients. Conclusions Limiting cervical smears to those who are symptomatic, or where an abnormality is found on examination, would save approximately 3500 per year. This cost needs to be set beside the possibility of detecting an asymptomatic recurrence at an early stage as reported by others. This suggests that the impact of this strategy is limited. A randomized trial with prospective economic assessment would be the only way to evaluate the costeffectiveness of routine cervical smears in the followup of patients treated for cancer of cervix.

Journal

Journal of Clinical EffectivenessEmerald Publishing

Published: Mar 1, 1997

There are no references for this article.